FLEURUS PHARMA
Money flows
no detail for 2017Balance sheet
balance sheet total €656,345 on 31-12-2017in euro
Staff
Staff costs divided by the average number of full-time equivalents.
Key figures and ratios
per financial year, computed from the annual accounts| Line | Trend | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 66,956 | 43,172 | 120,937 | 169,045 | 151,587 | 134,072 | 79,991 | 88,373 | 113,708 | 126,944 | 94,767 | 116,849 | ||
| 59,919 | 21,162 | 166,106 | 141,004 | 124,111 | 95,978 | 53,282 | 60,903 | 83,852 | 91,153 | 56,316 | 85,097 | ||
| 0 | 6,820 | 24,835 | 419 | 1,155 | 74,488 | 450,691 | 39,847 | 108,025 | 12,875 | 1,977 | 860,453 | ||
| - | - | -24,847 | 92,493 | 35,860 | -144,543 | 104,559 | 68,063 | -58,834 | 67,233 | -24,764 | - | ||
| 295,160 | 277,335 | 293,297 | 190,300 | 94,113 | 19,213 | -136,894 | -19,828 | -92,285 | -116,437 | -152,995 | -153,164 | ||
| - | -2.5% | - | - | - | - | -1.8% | 2.6% | 2.7% | - | - | - | ||
| 35.7% | 32.3% | 30.5% | 23.4% | 17.6% | 14.3% | 10.5% | 28.7% | 22.5% | 21.2% | 20.8% | 20.9% | ||
| 10.27 | 7.04 | 3.25 | 2.33 | 1.53 | 1.10 | 0.82 | 0.93 | 0.66 | 0.69 | 0.52 | 0.58 | ||
| 10.27 | 7.04 | 2.51 | 1.73 | 0.89 | 0.57 | 0.37 | 0.61 | 0.35 | 0.45 | 0.27 | 0.35 | ||
| 1.80 | 2.10 | 2.27 | 3.27 | 4.70 | 5.97 | 8.48 | 2.48 | 3.44 | 3.72 | 3.80 | 3.78 | ||
| 2.6% | -14.4% | 24.5% | 21.8% | 13.6% | -6.9% | -32.7% | 0.9% | -0.3% | 3.2% | -14.6% | 3.9% | ||
| 0.9% | -4.6% | 7.5% | 5.1% | 2.4% | -1.0% | -3.4% | 0.2% | -0.1% | 0.7% | -3.0% | 0.8% | ||
| - | 58 days | - | - | - | - | 21 days | 23 days | 21 days | - | - | - | ||
| 166 days | 6 days | - | - | - | - | 108 days | 27 days | 24 days | - | - | - |
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
Filed annual accounts
as filed with the National Bank, click a year to choose it| Line | Trend | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance sheet: assets | |||||||||||||
20/58 |
656,345 | 706,435 | 854,073 | 841,396 | 876,469 | 927,137 | 1.3m | 656,471 | 830,800 | 886,018 | 871,554 | 995,802 | |
21/28 |
329,341 | 383,186 | 430,316 | 507,630 | 605,211 | 707,306 | 738,157 | 385,437 | 653,884 | 630,280 | 702,647 | 783,481 | |
21 |
- | - | - | 33,100 | 66,200 | 99,300 | 132,400 | 165,500 | 198,600 | 231,700 | 264,800 | 297,900 | |
22/27 |
329,341 | 383,186 | 430,316 | 474,530 | 539,011 | 608,006 | 605,551 | 219,731 | 455,078 | 398,374 | 437,641 | 485,375 | |
22 |
289,485 | 330,442 | 247,606 | 266,140 | 284,666 | 303,192 | 267,677 | 130,206 | 343,879 | 262,945 | 284,634 | 306,323 | |
23 |
- | - | 116,973 | 135,984 | 156,790 | 181,818 | 187,235 | 4,150 | 7,770 | 13,684 | 25,821 | 36,590 | |
24 |
39,856 | 52,744 | 65,737 | 72,406 | 97,556 | 122,997 | 150,639 | 85,375 | 103,428 | 121,744 | 127,186 | 142,463 | |
28 |
- | - | - | - | - | - | 206 | 206 | 206 | 206 | 206 | 206 | |
29/58 |
327,004 | 323,249 | 423,757 | 333,766 | 271,257 | 219,831 | 610,133 | 271,033 | 176,916 | 255,739 | 168,907 | 212,321 | |
3 |
- | - | 96,804 | 85,265 | 113,142 | 104,803 | 335,774 | 93,256 | 84,025 | 89,466 | 80,425 | 84,825 | |
30/36 |
- | - | 96,804 | 85,265 | 113,142 | 104,803 | 335,774 | 93,256 | 84,025 | 89,466 | 80,425 | 84,825 | |
40/41 |
117,927 | 68,379 | 72,127 | 61,952 | 64,061 | 56,833 | 71,621 | 79,599 | 62,776 | 77,322 | 66,764 | 76,015 | |
40 |
- | - | 71,821 | 61,952 | 63,519 | 56,626 | 64,404 | 72,648 | 62,675 | 73,894 | 61,764 | 73,895 | |
41 |
117,927 | 68,379 | 306 | - | 542 | 207 | 7,217 | 6,950 | 101 | 3,429 | 5,000 | 2,120 | |
50/53 |
- | 254,870 | - | - | - | - | - | - | - | - | - | - | |
54/58 |
209,077 | - | 161,701 | 186,548 | 94,055 | 58,195 | 202,738 | 98,179 | 30,116 | 88,950 | 21,717 | 46,481 | |
490/1 |
- | - | 93,124 | - | - | - | - | - | - | - | - | 5,000 | |
| Balance sheet: equity and liabilities | |||||||||||||
10/49 |
656,345 | 706,435 | 854,073 | 841,396 | 876,469 | 927,137 | 1.3m | 656,471 | 830,800 | 886,018 | 871,554 | 995,802 | |
10/15 |
234,133 | 228,059 | 260,847 | 196,890 | 153,886 | 133,025 | 142,179 | 188,606 | 186,970 | 187,539 | 181,629 | 208,125 | |
10/11 |
200,000 | 200,000 | 200,000 | 200,000 | 200,000 | 200,000 | 200,000 | 200,000 | 200,000 | 200,000 | 200,000 | 200,000 | |
100 |
200,000 | 200,000 | 200,000 | 200,000 | 200,000 | 200,000 | 200,000 | 200,000 | 200,000 | 200,000 | 200,000 | 200,000 | |
13 |
3,910 | 3,606 | 3,606 | 406 | 406 | 406 | 406 | 406 | 406 | 406 | 406 | 406 | |
130 |
3,910 | 3,606 | 3,606 | 406 | 406 | 406 | 406 | 406 | 406 | 406 | 406 | 406 | |
14 |
30,223 | 24,453 | 57,241 | -3,516 | -46,520 | -67,381 | -58,227 | -11,800 | -13,436 | -12,867 | -18,777 | 7,719 | |
17/49 |
422,212 | 478,376 | 593,226 | 644,506 | 722,582 | 794,112 | 1.2m | 467,865 | 643,830 | 698,479 | 689,925 | 787,678 | |
17 |
390,368 | 432,462 | 462,766 | 500,725 | 543,388 | 593,178 | 459,083 | 176,414 | 374,629 | 326,304 | 367,951 | 422,192 | |
170/4 |
390,368 | 432,462 | 462,766 | 500,725 | 543,388 | 593,178 | 459,083 | 176,414 | 374,629 | 326,304 | 367,951 | 422,192 | |
42/48 |
31,844 | 45,914 | 130,460 | 143,466 | 177,144 | 200,619 | 747,027 | 290,861 | 269,201 | 372,175 | 321,902 | 365,485 | |
42 |
29,732 | 30,618 | 37,959 | 42,563 | 49,790 | 47,891 | 44,244 | 23,109 | 50,599 | 55,423 | 54,241 | 47,835 | |
43 |
- | - | - | - | - | - | - | - | - | - | - | 19,715 | |
430/8 |
- | - | - | - | - | - | - | - | - | - | - | 19,715 | |
44 |
2,112 | 6,109 | 39,022 | 18,630 | 45,563 | 69,388 | 284,695 | 73,694 | 60,964 | 114,226 | 58,249 | 77,605 | |
440/4 |
2,112 | 6,109 | 39,022 | 18,630 | 45,563 | 69,388 | 284,695 | 73,694 | 60,964 | 114,226 | 58,249 | 77,605 | |
45 |
- | 1,654 | 44,296 | 14,935 | 12,487 | 13,801 | 19,601 | 11,203 | 10,674 | 11,332 | 12,494 | 11,616 | |
450/3 |
- | 1,654 | 25,334 | 3,084 | 1,458 | 3,068 | 6,626 | 1,685 | 2,996 | 3,990 | 3,070 | 1,715 | |
454/9 |
- | - | 18,963 | 11,850 | 11,029 | 10,733 | 12,974 | 9,518 | 7,678 | 7,342 | 9,424 | 9,900 | |
47/48 |
- | 7,533 | 9,183 | 67,338 | 69,305 | 69,538 | 398,486 | 182,855 | 146,965 | 191,194 | 196,919 | 208,715 | |
492/3 |
- | - | - | 315 | 2,050 | 315 | - | 590 | - | - | 72 | - | |
| Income statement | |||||||||||||
70 |
- | 433,300 | - | - | - | - | 1.1m | 1.1m | 1.1m | - | - | - | |
76A |
- | - | 101,676 | - | - | - | 1,736 | 8,372 | - | - | - | - | |
9900 |
68,264 | 85,406 | 232,566 | 261,663 | 236,425 | 214,068 | 155,548 | 159,050 | 173,377 | 178,394 | 166,641 | 187,168 | |
60/61 |
4,639 | 396,404 | - | - | - | - | 964,030 | 987,317 | 930,006 | - | - | - | |
62 |
175 | 38,854 | 111,627 | 90,779 | 84,838 | 79,667 | 75,322 | 70,677 | 59,669 | 51,450 | 71,721 | 70,188 | |
630 |
53,845 | 53,950 | 102,149 | 98,000 | 103,249 | 105,133 | 99,708 | 59,267 | 84,421 | 85,243 | 82,811 | 76,972 | |
640/8 |
1,133 | 3,380 | 1 | 1,838 | - | 329 | 235 | - | - | - | 153 | 132 | |
9901 |
13,111 | -10,778 | 18,788 | 71,045 | 48,337 | 28,940 | -19,717 | 29,106 | 29,287 | 41,702 | 11,956 | 39,876 | |
75/76B |
34 | 100 | 367 | 198 | 3,251 | 1,083 | 3,058 | 3,735 | 4,467 | 2,442 | 2,593 | 381 | |
75 |
34 | 100 | 367 | 198 | 3,251 | 1,083 | 3,058 | 3,735 | 4,467 | 2,442 | 2,593 | 381 | |
65/66B |
7,067 | 22,106 | 33,491 | 28,103 | 30,589 | 39,013 | 33,108 | 39,577 | 34,323 | 36,628 | 41,045 | 31,171 | |
65 |
7,067 | 22,106 | 33,491 | 28,103 | 30,589 | 39,013 | 33,108 | 39,577 | 34,323 | 36,628 | 41,045 | 31,171 | |
9903 |
6,078 | -32,784 | 87,341 | 43,139 | 21,000 | -8,990 | -48,031 | 1,636 | -569 | 7,515 | -26,496 | 9,086 | |
67/77 |
4 | 4 | 23,384 | 136 | 138 | 164 | -1,605 | - | - | 1,605 | - | 961 | |
9904 |
6,074 | -32,788 | 63,957 | 43,004 | 20,861 | -9,155 | -46,426 | 1,636 | -569 | 5,910 | -26,496 | 8,125 | |
9905 |
6,074 | -32,788 | 63,957 | 43,004 | 20,861 | -9,155 | -46,426 | 1,636 | -569 | 5,910 | -26,496 | 8,125 | |
| Appropriation of the result | |||||||||||||
9906 |
30,527 | 24,453 | 60,441 | -3,516 | -46,520 | -67,381 | -58,227 | -11,800 | -13,436 | -12,867 | -18,777 | 8,125 | |
691/2 |
304 | - | 3,200 | - | - | - | - | - | - | - | - | 406 | |
6920 |
304 | - | 3,200 | - | - | - | - | - | - | - | - | 406 | |
| Social balance sheet | |||||||||||||
9087 |
- | 0.8 | 2.3 | 2 | 1.8 | 1.8 | 1.7 | 1.7 | 1.3 | 1.3 | 1.3 | 1.9 | |
Hours worked1013 |
- | 1,528 | 4,505 | 3,848 | 3,575 | 3,461 | 2,957 | 2,963 | 2,252 | 2,222 | 3,168 | 3,477 | |
| Document | |||||||||||||
Source: Annual accounts 2017 (PDF), filed on 14-08-2018.
Filings
each dot is a set of accounts, on the day it reached the National BankThe accounts were filed on 14-08-2018. The deadline was 31-07-2018, 7 months after the close on 31-12-2017. Source: NBB, 2018-45900522.
| Financial year | Type | Filed | Reference | Document |
|---|---|---|---|---|
| 31-12-2017 | full format | 14-08-2018 | 2018-45900522 | |
| 31-12-2016 | full format | 28-08-2017 | 2017-53200382 | |
| 31-12-2015 | full format | 20-07-2016 | 2016-35000022 | |
| 31-12-2014 | full format | 31-07-2015 | 2015-40100169 | |
| 31-12-2013 | full format | 05-08-2014 | 2014-40300275 | |
| 31-12-2012 | full format | 13-08-2013 | 2013-42400391 | |
| 31-12-2011 | full format | 13-07-2012 | 2012-30400233 | |
| 31-12-2010 | full format | 30-08-2011 | 2011-51500201 | |
| 31-12-2009 | full format | 03-11-2010 | 2010-60000025 | |
| 31-12-2008 | full format | 13-08-2009 | 2009-58700210 | |
| 31-12-2007 | full format | 17-10-2008 | 2008-78800112 | |
| 31-12-2006 | full format | 06-07-2007 | 2007-37200287 |
Insights on FLEURUS PHARMA
The operating result for 2017 is a profit of €13,111, after a loss of €10,778 in 2016.
Debt's share of the balance-sheet total falls from 67.7% to 64.3%. Equity is higher and debt is lower.